Step 1 topics → Microbiology → Other Staphylococci

Other Staphylococci

USMLE Step 1 trap: Confuses S. epidermidis coagulase status with S. aureus. S. epidermidis is coagulase-negative, which is the key lab feature distinguishing it from S. aureus.

Other staphylococci — primarily S. epidermidis and S. saprophyticus — are the coagulase-negative members of the staph family that USMLE Step 1 tests as a direct contrast to S. aureus. The most costly error on these vignettes is dismissing S. epidermidis as a contaminant: it is a legitimate pathogen in any patient with an implanted foreign device, where it forms biofilms that resist antibiotics and often require device removal for cure. The core framework is coagulase negativity to rule out S. aureus, then novobiocin sensitivity to separate S. epidermidis (sensitive) from S. saprophyticus (resistant). The exam presents these through short vignettes where patient population or device history is the key clue.

The tricky part is that students over-anchor on S. aureus when they see 'Staphylococcus' and either forget the coagulase-negative distinction entirely or conflate the two coagulase-negative species with each other. S. epidermidis lives on everyone's skin and gets dismissed as a contaminant — that mental habit will cost you points when the vignette describes a prosthetic valve, hip replacement, or central line in a patient who is immunocompromised. S. saprophyticus trips students up because E. coli is so dominant in the UTI framework that the second most common cause in young sexually active women gets overlooked entirely.

On USMLE Step 1, these organisms appear in application-level questions: given a clinical vignette (catheter-associated bacteremia, post-op prosthetic device infection, UTI in a college-age woman), you need to identify the bug, know its lab features, and understand the mechanism of pathogenicity — especially biofilm formation for S. epidermidis. Pure recall of lab results alone is not enough; the exam expects you to integrate the patient population with the microbiology.

From real student decks
86%have cards covering this topic
76%have mature cards

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Wrong: S. epidermidis is coagulase-positive like S. aureus.
Right: S. epidermidis is coagulase-negative, which is the key lab feature distinguishing it from S. aureus.
S. epidermidis is coagulase-negative — this is the single most important lab feature separating it from S. aureus. Coagulase converts fibrinogen to fibrin and is a virulence factor unique to S. aureus; lacking it is literally what defines the 'coagulase-negative staph' group. When you see coagulase-negative on a lab result, immediately rule out S. aureus and pivot to S. epidermidis or S. saprophyticus based on clinical context.
Common mistake
Wrong: S. saprophyticus is novobiocin-sensitive like S. epidermidis.
Right: S. saprophyticus is novobiocin-resistant, which distinguishes it from S. epidermidis on lab testing.
S. saprophyticus is novobiocin-resistant, while S. epidermidis is novobiocin-sensitive — this is the standard lab test used to tell them apart once you've confirmed coagulase negativity. A helpful memory anchor: 'SAP is resistant' — S. SAProphyticus, Resistant. If you mix these up on a lab interpretation question, you'll misidentify the organism even after correctly recognizing it's coagulase-negative.
Common mistake
Wrong: S. epidermidis is non-pathogenic because it is normal skin flora.
Right: S. epidermidis causes serious infections in immunocompromised patients and those with prosthetic devices via biofilm formation.
Being normal skin flora does not make S. epidermidis harmless — it just means it's usually kept in check by intact host defenses. When a prosthetic device, catheter, or shunt bypasses those defenses, S. epidermidis uses its ability to produce a polysaccharide biofilm to adhere, persist, and cause serious infection. This biofilm also makes it resistant to many antibiotics, which is why device removal is often required for cure.
Common mistake
Wrong: E. coli is always the cause of UTI in young sexually active women.
Right: S. saprophyticus is the second most common cause of UTI in young sexually active women and must be distinguished from E. coli.
E. coli causes the majority of UTIs but is not the answer every time — S. saprophyticus is the second most common cause specifically in young, sexually active women, and the USMLE Step 1 loves this demographic clue. If the vignette emphasizes a college-age woman with a new sexual partner and dysuria, think S. saprophyticus first. The organism's tropism for this population is not random; it has specific uroepithelial adhesins that make it fit this clinical niche.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Given a vignette describing a patient with a prosthetic device or central line who develops bacteremia, identify S. epidermidis based on its coagulase-negative lab result and ability to form biofilms on foreign surfaces.
  2. Distinguish S. epidermidis from S. aureus using the coagulase test, and understand why coagulase negativity is the defining lab feature of this group.
  3. Identify S. saprophyticus as the causative organism in a UTI vignette featuring a young, sexually active woman, and know that it is coagulase-negative and novobiocin-resistant.
  4. Differentiate S. epidermidis from S. saprophyticus using novobiocin sensitivity testing — S. epidermidis is novobiocin-sensitive; S. saprophyticus is novobiocin-resistant.
  5. Recognize that S. epidermidis is a legitimate pathogen — not merely a contaminant — in immunocompromised patients and those with implanted foreign material, operating through biofilm formation.

Can you avoid these mistakes?

A 24-year-old woman presents with dysuria and urinary frequency. She recently became sexually active. Urine culture grows gram-positive cocci in clusters that are coagulase-negative and novobiocin-resistant. What is the organism, and why does novobiocin resistance matter here?
A 65-year-old man with a prosthetic aortic valve develops fever and bacteremia 3 months after valve replacement. Blood cultures grow coagulase-negative gram-positive cocci. Why is this organism not simply a contaminant, and what is the mechanism by which it persists on the prosthetic valve?
You see two lab results: Organism A is coagulase-negative and novobiocin-sensitive. Organism B is coagulase-negative and novobiocin-resistant. Match each organism to its name and most classic clinical scenario.
A patient recovering from hip arthroplasty develops a low-grade fever and elevated ESR. Cultures from the joint aspirate grow coagulase-negative staph. A medical student dismisses it as a skin contaminant. What is wrong with that reasoning, and what feature of this organism explains why implanted devices are high-risk?

Related topics

Bacterial Staining and Structure Bacterial Culture Requirements Encapsulated Organisms Bacterial Exotoxins

See how your Anki deck covers this topic.

Upload your deck for a free audit →